Filing Details
- Accession Number:
- 0001618835-19-000183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-21 20:18:09
- Reporting Period:
- 2019-11-20
- Accepted Time:
- 2019-11-21 20:18:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1618835 | Evofem Biosciences Inc. | EVFM | Pharmaceutical Preparations (2834) | 208527075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726277 | J. Justin File | C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-20 | 10,102 | $5.74 | 207,353 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-11-20 | 100 | $6.00 | 207,253 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-21 | 4,900 | $6.00 | 202,353 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 20, 2019. No shares were sold in connection with this transaction.
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019.
Billionaire Hedge Funds
